Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-06T16:46:33.619Z Has data issue: false hasContentIssue false
  • English
  • Français

A response to Birch and Gafni – some reasons to be cheerful about NICE

Published online by Cambridge University Press:  01 April 2007

MARTHE GOLD  and
STIRLING BRYAN
MARTHE GOLD*
Affiliation:
Professor and Chair, Department of Community Health and Social Medicine, City University of New York Medical School, New York, USA
STIRLING BRYAN
Affiliation:
Professor of Health Economics and Director of the Health Economics Facility at University of Birmingham, UK
*
*Correspondence to: Marthe Gold MD, MPH, Department of Community Health and Social Medicine, City University of New York Medical School, 138th Street and Convent Avenue – Harris 406, New York, NY 10031, USA. Email: goldmr@med.cuny.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Response
Information
Health Economics, Policy and Law , Volume 2 , Issue 2 , April 2007 , pp. 209 - 216
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Birch, S. and Gafni, A. (2002), ‘On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales’, Health Economics, 11: 185–191.CrossRefGoogle ScholarPubMed
Braveman, P. and Gruskin, S. (2003), ‘Defining equity in health’, Journal of Epidemiology and Community Health, 57: 254–258.CrossRefGoogle ScholarPubMed
Bryan, S., Williams, I. and McIver, S. (2007), ‘Seeing the NICE side of cost-effectiveness analyses: a qualitative investigation of the use of CEA in NICE technology appraisals’, Health Economics.CrossRefGoogle ScholarPubMed
Cookson, R., McDaid, D. and Maynard, A. (2001), ‘Wrong SIGN, NICE mess: is national guidance distorting allocation of resources?’, British Medical Journal, 323: 743–745.CrossRefGoogle ScholarPubMed
Davies, E. and Littlejohns, P. (2002), ‘Views of Directors of Public Health about NICE appraisal guidance: results of a postal survey’, Journal of Public Health Medicine, 24(4): 319–325.CrossRefGoogle ScholarPubMed
Department of Health (2006), ‘Departmental Report’, CM 6814, Department of Health Departmental Report, Presented to Parliament by the Secretary of State for Health and the Chief Secretary to the Treasury, May 2006.Google Scholar
Devlin, N. and Parkin, D. (2004), ‘Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis’, Health Economics, 13(5): 437–452.CrossRefGoogle ScholarPubMed
Fleck, L. (2006), ‘The costs of caring: Who pays? Who profits? Who panders?’, Hastings Center Report, 36(3): 13–17.CrossRefGoogle ScholarPubMed
Gafni, A. and Birch, S. (2003), ‘Inclusion of drugs in provincial benefit programs: should “reasonable decisions” lead to uncontrolled growth in expenditures?’, Canadian Medical Association Journal, 168: 849–851.Google ScholarPubMed
Garber, A.M. (2004), ‘Cost-effectiveness and evidence evaluation as criteria for coverage policy’, Health Affairs, Web exclusive, 19 May: 284–296.Google ScholarPubMed
Gold, M.R., Siegel, J.S.Russell, L. and Weinstein, M. (1996), Cost-effectiveness in Health and Medicine, New York: Oxford University Press.CrossRefGoogle ScholarPubMed
Holahan, J. and Cook, A. (2005), ‘Changes in economic conditions and health insurance coverage, 2000–2004’, Health Affairs, 24, S3, W5: 489–508.Google Scholar
Patented Medicine Price Review Board (2006), ‘Non-patented prescription drug prices reporting: Canadian and foreign price trends’, accessed 25 August 2006 at http://www.pmprb-cepmb.gc.ca/english/view.asp?x=496.Google Scholar
Sculpher, M., Drummond, M. and O’Brien, B. (2001), ‘Effectiveness, efficiency and NICE’, British Medical Journal, 322: 943–944.CrossRefGoogle ScholarPubMed
Smith, C., Cowan, C.Sensenig, A. and Catlin, A. (2006), ‘Health spending growth slows in 2004’, Health Affairs, 25(1): 186–196.CrossRefGoogle ScholarPubMed
Williams, I. and Bryan, S. (under review), ‘Cost effectiveness analysis and formulary decision making: evidence based policy or muddling through?’ (under review)Google Scholar
Williams, I., Bryan, S. and McIver, S. (2007), ‘How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the NICE approach’, Journal of Health Services Research and Policy.CrossRefGoogle Scholar